重组细胞因子

• DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury. ACS Appl Mater Interfaces. 2024 Jul 19. (IF 8.7)(Mouse M-CSF)
• Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy. Adv Mater. 2024 Jul 18:e2406140. (IF 27.4)(Mouse CCL2)
• Lyssavirus matrix protein inhibits NLRP3 inflammasome assembly by binding to NLRP3. Cell Rep. 2024 Jul 9;43(7):114478. (IF 7.5)(Mouse GM-CSF)
• Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis. Sci Adv. 2024 Jun 28;10(26):eado6798. (IF11.7)(Mouse IL-4)
• RTP4 restricts lyssavirus rabies infection by binding to viral genomic RNA. Veterinary Microbiology. 19 June 2024, 110159. (IF 2.4)(Mouse IFN-β)
• Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis. J Inflamm Res. 2024 Apr 15:17:2285-2298. (IF 4.2)(Human IL-4)